Oxygenta Pharmaceutical Ltd share price logo

Oxygenta Pharmaceutical Share Price

BSE: 524636

Small Cap

Healthcare Sector

₹63.00

+3.10

(+5.18%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Oxygenta Pharmaceutical Stock Performance

as on January 30, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹58.70
    ₹64.00
    downward going graph

    6.83%

    Downside

    1.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹51.31
    ₹133.50
    downward going graph

    18.56%

    Downside

    111.90%

    Upside

    downward going graph

Oxygenta Pharmaceutical share price movements today

Previous Close
₹59.90
Open
₹58.70
Volume
13.24K
Upper Circuit
₹65.89
Lower Circuit
₹53.91
Day's Low - High
₹58.70 - ₹64.00
52 Week Low - High
₹51.31 - ₹133.50

Oxygenta Pharmaceutical Historical Returns

1 Month Return
+ 12.4 %
3 Month Return
-1.52 %
1 Year Return
-20.97 %
3 Year Return
+ 115.5 %
5 Year Return
+ 555.28 %

Oxygenta Pharmaceutical Fundamentals

as on January 30, 2026 at 4:01 pm IST

Market Cap

₹231.92 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

0.97

P/B Ratio

-11.75

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

72.98

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Oxygenta Pharmaceutical Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oxygenta Pharmaceutical with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Oxygenta Pharmaceutical Ltd image
Oxygenta Pharmaceutical Ltd
NA231.92111.06%0.00-10109
Krebs Biochemicals & Industries Ltd image
Krebs Biochemicals & Industries Ltd
NA126.82-9.5%0.00-2743
Curis Lifesciences Ltd image
Curis Lifesciences Ltd
NA84.56-5.16%0.00649
Remedium Lifecare Ltd image
Remedium Lifecare Ltd
NA73.2117.73%0.982405
Neuland Laboratories Ltd image
Neuland Laboratories Ltd
BUY17,000.89179.08%0.552601,476
See all

Oxygenta Pharmaceutical Share Price Target

Get share price movements and forecasts by analysts on Oxygenta Pharmaceutical .

Source: S&P Global Market Intelligence

Oxygenta Pharmaceutical Stock’s Investor Sentiment and Interest

Search interest for Oxygenta Pharmaceutical Ltd Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-12% versus previous 30 day period

Oxygenta Pharmaceutical Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
8.19
6.86
13.08
9.15
10.55
12.62
14.01
33.21
49.47
15.13
14.3
Other Income
-
-
-
0.03
0.26
0.02
0.75
0.49
0.05
0.17
-0.06
Total Income
8.19
6.86
13.08
9.18
10.81
12.64
14.75
33.69
49.52
15.3
14.25
Expenses
10.49
10.63
15.08
11.67
12.17
14.4
16.18
37.56
51.42
21.98
18.88
Operating Profit
-2.3
-3.77
-2
-2.52
-1.62
-1.78
-2.17
-4.35
-1.95
-6.85
-4.58
Operating Profit Margin %
-28.08%
-54.96%
-15.29%
-27.54%
-15.36%
-14.1%
-15.49%
-13.1%
-3.94%
-45.27%
-32.03%
Profit Before Interest, Tax and Depreciation
-2.3
-3.76
-2
-2.49
-1.35
-1.76
-1.42
-3.87
-1.9
-6.67
-4.63
Interest
0.94
0.29
0.34
0.36
0.59
0.41
0.69
0.39
2.13
0.63
0.95
Depreciation
0.85
0.5
0.83
0.69
0.64
0.65
0.66
0.71
-0.23
0.85
0.86
Profit Before Tax
-4.09
-4.55
-3.17
-3.54
-2.58
-2.82
-2.77
-4.97
-3.8
-8.15
-6.44
Tax Paid
0.2
-
-0.02
0.23
-10.6
-1.45
0.08
-1.03
-1.65
-2.04
-1.51
Profit After Tax
-4.29
-4.56
-3.16
-3.78
8.02
-1.36
-2.85
-3.93
-2.15
-6.11
-4.93
Total Net profit including share of profit / Loss from associate company
-4.29
-4.56
-3.16
-3.78
8.02
-1.36
-2.85
-3.93
-2.15
-6.11
-4.93
EPS
-3.02
-1.65
-0.87
-1.12
2.55
-0.39
-0.81
1.07
-0.6
-1.65
-1.33
Actual EPS
-3.02
-1.65
-0.87
-1.12
2.55
-0.39
-0.81
1.07
-0.6
-1.65
-1.33
Adjusted EPS
-3.02
-1.65
-0.87
-1.12
2.55
-0.39
-0.81
1.07
-0.6
-1.65
-1.33
Diluted EPS
-3.02
-1.65
-0.76
-1.07
2.44
-0.37
-0.78
1.07
-0.6
-1.65
-1.33

Oxygenta Pharmaceutical Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
8.15
12.87
20.51
13.72
52.03
60.52
30.99
39.64
109.3
Other Income
0.62
1.36
0.31
4.02
2.28
0.55
0.02
0.08
1.31
Total Income
8.77
14.23
20.82
17.74
54.31
61.08
31.01
39.72
110.61
Expenses
13
16.87
22.55
21.58
48.2
59.05
38.84
49.34
119.56
Operating Profit
-4.85
-4
-2.04
-7.86
3.83
1.47
-7.85
-9.7
-10.26
Operating Profit Margin %
-59.51%
-31.08%
-9.95%
-57.29%
7.36%
2.43%
-25.33%
-24.47%
-9.39%
Profit Before Interest, Tax and Depreciation
-4.23
-2.64
-1.73
-3.85
6.1
2.03
-7.83
-9.62
-8.96
Interest
0.6
0.9
0.75
1.09
1.78
0.92
1.49
1.59
1.78
Depreciation
0.9
0.94
1.02
1
1.2
1.59
2.05
2.66
3.61
Profit Before Tax
-5.73
-4.48
-3.5
-5.94
3.12
-0.48
-11.37
-13.87
-14.35
Tax Paid
0.09
0.05
-0.24
-0.15
0.19
0.12
0.2
-10.39
-4.05
Profit After Tax
-5.81
-4.53
-3.25
-5.79
2.93
-0.61
-11.57
-3.48
-10.3
Total Net profit including share of profit / Loss from associate company
-5.81
-4.53
-3.25
-5.79
2.93
-0.61
-11.57
-3.48
-10.3
EPS
-5.69
-4.44
-3.19
-5.67
2.87
-0.48
-6.36
-1.09
-2.86
Actual EPS
-5.69
-4.44
-3.19
-5.67
2.87
-0.48
-6.36
-1.09
-2.86
Adjusted EPS
-5.69
-4.44
-3.19
-5.67
2.87
-0.48
-6.36
-1.09
-2.86
Diluted EPS
-5.69
-4.44
-3.19
-5.67
2.87
-0.48
-6.36
-1.04
-2.86

Oxygenta Pharmaceutical Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.85
0.52
1.28
-7.79
-2.59
-1.62
-1.68
-1.63
-13.05
2.6
Cash Flow from Investing Activities
-2.08
-0.9
-0.39
-0.56
-0.5
-6.72
-4.95
-9.63
-4.09
-11.25
Cash Flow from Financing Activities
1.17
0.39
-0.9
8.35
3.19
8.67
6.34
11.22
17.14
8.67
Net Cash Flow
-0.06
0.01
-0.01
0.01
0.1
0.33
-0.29
-0.05
-0.01
0.02

Oxygenta Pharmaceutical Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
8.99%
26.8%
29.73%
29.73%
29.73%
33.69%
53.28%
51.12%
51.12%
57.95%
57.95%
55.93%
DII
0.07%
0.03%
0.03%
0.03%
0.03%
0.03%
0.03%
0.03%
0.03%
0.03%
0.03%
0.03%
Public
90.94%
73.18%
70.25%
70.25%
70.25%
66.29%
46.69%
48.85%
48.85%
42.02%
42.02%
44.04%
Total Outstanding Shares
1,42,01,300
3,34,83,500
3,34,83,500
3,34,83,500
3,34,83,500
3,54,83,500
3,54,83,500
3,69,83,500
3,69,83,500
3,69,83,500
3,69,83,500
3,69,83,500
Total Shareholders
8,995
8,987
8,972
9,051
10,102
9,970
10,154
10,107
10,030
10,094
10,179
10,215

Oxygenta Pharmaceutical Corporate Actions

View detailed summary of the earnings and dividend history of Oxygenta Pharmaceutical .

  • Oxygenta Pharmaceutical Ltd Earnings Results

    Oxygenta Pharmaceutical Ltd’s net profit fell -72.98% since last year same period to ₹-4.93Cr in the Q2 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 19.31% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Oxygenta Pharmaceutical Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 57.92% to 57.95% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Oxygenta Pharma stock has moved up by 12.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 160.3% return, outperforming this stock by 44.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 21.2% return, outperforming this stock by 42.1%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 42.06% to 42.02% in Sep 2025 quarter

About Oxygenta Pharmaceutical Ltd

SS Organics Ltd is a public limited company engaged in the manufacturing of bulk drugs and new-generation medications. Based in Medak, Andhra Pradesh, the company was established in 1990 as a private limited entity and subsequently got converted into a public limited company in 1993. Their extensive product range includes antiasthmatic, antiulcerant and antiinflammatory drugs. With these latest generation medications, SS Organics Ltd is a reliable name in manufacturing and supplying quality bulk drugs to customers in India and abroad.

Revenue: ₹14.30Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-4.93Cr as on September 2025 (Q2 FY26)
Chairperson Name: Sai Sudhakar Vankineni
OrganisationOxygenta Pharmaceutical Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOSai Sudhakar Vankineni
E-voting on sharesClick here to vote

FAQs

What is Oxygenta Pharmaceutical share price today?

Oxygenta Pharmaceutical share price today stands at ₹63 as on at the close of the market. Oxygenta Pharmaceutical share today touched a day high of ₹64 and a low of ₹58.7.

What is the 52 week high and 52 week low range for Oxygenta Pharmaceutical share?

Oxygenta Pharmaceutical touched a 52 week high of ₹133.5 and a 52 week low of ₹51.31. Oxygenta Pharmaceutical share price today i.e. is closed at ₹63, which is -52.81% down from its 52 week high and 22.78% up from its 52 week low.

What is Oxygenta Pharmaceutical 's market capitalisation today?

Oxygenta Pharmaceutical market capitalisation is ₹231.92 Cr as on .

How to buy Oxygenta Pharmaceutical shares?

To buy Oxygenta Pharmaceutical shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524636 or Oxygenta Pharmaceutical Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Oxygenta Pharmaceutical shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Oxygenta Pharmaceutical trading volume today?

Oxygenta Pharmaceutical trading volume is 13.24K as on . This means that 13.24K shares of Oxygenta Pharmaceutical were bought and sold on the stock market during today's trading session.